Mirror Journaling App Study

NCT07126275 | Active Not Recruiting

• 1 other identifier: Pro00080718
• Study Type: interventional
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

This study has three primary aims: 1) Validate Mirror's Mood Check feature by measuring convergent validity;2) Assess user experience and acceptability metrics (e.g., usability, engagement, satisfaction) of the Mirror app, with a particular focus on the journaling feature; 3) Assess the impact of guided journaling and mood tracking on depressive and anxious symptoms.

Conditions

Depression Symptoms; Anxiety Symptoms

Outcome Measures

Primary Outcomes (3)

• Depressive Symptoms

  Statistical models including ANOVA and regression will be used to compare changes in depressive symptoms across the four groups. Changes in depressive symptoms will be assessed with the PROMIS Depression Short Form, which has scores that range from 8-40, with higher scores indicating greater depressive symptom severity. PROMIS was measured at baseline, post-intervention (8 weeks), and at a 1-month follow-up. PHQ-8 was administered at baseline as a screening instrument to determine eligibility and was also administered at the 8-week assessment. PHQ-8 was not administered at the 1-month follow-up. This record update corrects an administrative error in the original ClinicalTrials.gov registration, which listed PHQ-8 and GAD-7 as primary outcomes and omitted the PROMIS measures. The IRB-approved protocol dated February 10, 2025, prior to study initiation, specified PROMIS and WHODAS as outcome measures. This update aligns the registration record with the approved protocol.

  12 weeks (including 1 month follow up)

• Anxiety Symptoms

  Statistical models including ANOVA and regression will be used to compare changes in anxiety symptoms across the four groups. Changes in anxiety symptoms will be assessed with the PROMIS Anxiety Short Form, which has scores that range from 7-35, with higher scores indicating greater anxiety symptom severity. PROMIS was measured at baseline, post-intervention (8 weeks), and at a 1-month follow-up. GAD-7 was administered at baseline as a screening instrument to determine eligibility and was also administered at the 8-week assessment. GAD-7 was not administered at the 1-month follow-up. This record update corrects an administrative error in the original ClinicalTrials.gov registration, which listed PHQ-8 and GAD-7 as primary outcomes and omitted the PROMIS measures. The IRB-approved protocol dated February 10, 2025, prior to study initiation, specified PROMIS and WHODAS as outcome measures. This update aligns the registration record with the approved protocol.

  12 weeks (including 1 month follow up)

• Impairment

  Statistical models including ANOVA and regression will be used to compare changes in impairment across the four groups. Changes in impairment will be assessed with the WHO Disability Assessment Schedule (WHODAS 2.0), which has scores that range from 0-100 with higher scores indicating higher levels of impairment. Impairment will be measured at baseline, post 8-weeks of the intervention, and at a 1 month follow up.

  12 weeks (including 1 month follow up)

Secondary Outcomes (3)

• User Experience

  8 weeks

• User Experience

  8 weeks

• User Feedback

  8 weeks

Study Arms (4)

Mirror Guided Journaling + Mood Tracking

EXPERIMENTAL

Structured prompts and regular feedback to facilitate journaling, alongside daily mood tracking in the Mirror App.

Device: Mirror App Journaling and Mood Tracking Study

Mirror Unguided Journaling + Mood Tracking

EXPERIMENTAL

Free-form journaling with access to daily mood tracking in the Mirror app without specific guided prompts.

Device: Mirror App Journaling and Mood Tracking Study

Mirror Mood Tracking Only

EXPERIMENTAL

Daily mood tracking in the Mirror app, without any journaling component.

Device: Mirror App Journaling and Mood Tracking Study

Control Group

NO INTERVENTION

Information on mental health resources without journaling or mood tracking.

Interventions

Mirror App Journaling and Mood Tracking Study DEVICE

Mirror is a mobile journaling app developed by the Child Mind Institute (CMI) for youth who want to explore and improve their mental health, particularly addressing symptoms related to depression. The Mirror app enables users to express their thoughts and emotions through multimodal entries (i.e., written, voice, selfie video) and provides prompts to facilitate journal entries using unique, emotionally supportive features to help users identify and process emotions. Users can also complete free-form, unguided journaling, and can complete daily mood tracking and see changes/progress over time.

Mirror Guided Journaling + Mood Tracking; Mirror Mood Tracking Only; Mirror Unguided Journaling + Mood Tracking

Eligibility Criteria

• Age: 18 Years - 25 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Prolific users ages 18-25
• Must reside in the U.S.
• Must have access to a smart device, and are willing to download an external app (screened by Prolific Academic)
• Must complete screening form which consists of the Patient Health Questionnaire (PHQ-2) and the Generalized Anxiety Disorder (GAD-7) Scale.
• Must have mild to moderate depressive or anxiety symptoms, as measured by the screening form

You may not qualify if:

• \- None

Sponsors & Collaborators

• Child Mind Institute: lead

Study Sites (1)

Child Mind Institute

New York, New York, 10022, United States

Location

MeSH Terms

Conditions

Depression; Anxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Mental Disorders

Study Officials

• Michael Milham, MD, PhD

  Child Mind Institute

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 11, 2025
• First Posted: August 17, 2025
• Study Start: March 12, 2025
• Primary Completion: July 15, 2025
• Study Completion (Estimated): August 1, 2026
• Last Updated: March 10, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)